Premier Pharmacy Labs Recalls Neostigmine Methylsulfate Syringes Due to Labeling Error
Premier Pharmacy Labs is recalling Neostigmine Methylsulfate syringes because the printed beyond-use dates exceed current stability data.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error regarding stability dates, which fits the rubric criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Premier Pharmacy Labs, Inc. is recalling 1,610 syringes of Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable. The product is compounded for hospital and office use only. The recall involves three specific lots: NEO071317MMDSA, NEO071317MMDSC, and NEO071317MMDSF, all with a beyond-use date of 01/19/2018.
The recall was initiated due to a labeling error where the indicated beyond-use date exceeds current stability data. This means the expiration date printed on the product does not align with the available stability information for the compound.
The affected product was distributed to facilities in Michigan, Maryland, Minnesota, North Carolina, Ohio, and Florida. Healthcare providers and facilities should check their inventory for the specific lot numbers listed and discontinue use of the affected syringes.
The recalled product
- Product
- Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
- Manufacturer
- Premier Pharmacy Labs Inc
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1,610
Distribution
Related recalls
Same manufacturer · Premier Pharmacy Labs Inc
See all →- SeverePremier Pharmacy Labs Recalls Isoproterenol HCL Bags Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Succinylcholine Chloride Syringes for Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Phenylephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Droperidol Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Orphenadrine Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02